用草药和香料增加高血压成年人蔬菜消费的医学计划:随机对照可行性研究
Michelle Alcorn1, Allison Childress2, Wasiuddin Najam3
1Department of Hospitality and Retail Management, Texas Tech University, Lubbock, TX, USA.
American journal of health promotion : AJHP
|September 13, 2025
概括
使用草药和香料的6周虚拟医学 (CM) 计划改善了高血压成年人的饮食和健康. 这种可行的计划减少了,卡路里和脂肪摄入量,同时改善了纤维和血压.
科学领域:
- 营养科学 营养科学
- 心血管健康 心血管健康
- 数字健康干预措施 数字健康干预措施
背景情况:
- 不健康的饮食是导致高血压的主要原因之一.
- 医学 (CM) 将技巧与医学知识相结合,以促进更健康的饮食习惯.
- 需要通过饮食来管理高血压的可访问干预措施.
研究的目的:
- 评估电子CM教育计划的可行性,针对患有高血压的成年人.
- 评估该计划对饮食摄入量和健康结果的影响,重点关注草药和香料.
- 确定虚拟CM方法是否可以提高蔬菜消费和改善高血压管理.
主要方法:
- 一项为期6周的随机控制可行性研究,涉及17名高血压成年人.
- 参与者被分配到电子CM组 (e组) 或控制组 (c组).
- 电子小组收到了在线CM和营养教育视频,强调蔬菜增强的草药/香料;监测了饮食摄入量,体重和血压.
主要成果:
- 与c组相比,在一个月的随访中,e组的摄入量 (P = .008),热量 (P = .02) 和脂肪摄入量 (P = .005) 显著降低.
- 在e组中,从基线到随访期间观察到纤维摄入量 (P = .01) 和透气血压 (P = .003) 的显著改善.
- 虚拟CM计划是可行的,并得到了参与者的好评.
结论:
- 一个为期6周的虚拟医学计划,专注于草药和香料,对于患有高血压的成年人来说是可行的.
- 该计划导致了饮食行为中适度但显著的改善,包括减少,热量和脂肪摄入量.
- 这种数字健康干预措施有望通过饮食改变改善高血压患者的健康状况.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension I: Introduction
745
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
745
Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322

